Metabolomics News

WRAL Tech WireMetabolon CEO retires; company promotes chief business officer to top jobWRAL Tech WireMetabolon, which launched in 2000, defines metabolomics as the study of small molecules called metabolites and is a powerful phenotyping technology for precision medicine. It measures changes in metabolite levels and maps them to the appropriate ...

Triangle Business JournalMetabolon's longtime CEO retires, successor namedTriangle Business JournalRecent expansion abroad has included a new joint laboratory with Zhejiang Dian Diagnostics Co. in Hangzhou, China, that has achieved full validation for running the Metabolon metabolomics platform – used for studying small molecules for precision ...and more »

Metabolomics Market will Likely to Expand at a Steady CAGR of17.10% period of 2016 and 2024theperfectinvestor.comThe global metabolomics market has been witnessing an escalating graph of competition over the past years. At every point in time, the market has surpassed the previous levels of competition, and has led the major market players to lock horns with each ...and more »

Metabolics Core Fuels Innovative Research | University of Utah ...  University of Utah Health Sciences

Using a Benchtop GC-TOFMS for Metabolomic Profiling of Rice and Corn Extracts  AZoMGlobally, some of the most important crops for food, feed, and energy are rice and corn.1,2 Metabolomic profiling is one of the most effective methods for ...

Using a Benchtop GC-TOFMS for Metabolomic Profiling of Rice and Corn Extracts  AZoMGlobally, some of the most important crops for food, feed, and energy are rice and corn.1,2 Metabolomic profiling is one of the most effective methods for ...

GlobeNewswire (press release)Rohan Hastie Named as Metabolon CEO Following the Retirement of Its Co-Founder, John RyalsGlobeNewswire (press release)RESEARCH TRIANGLE PARK, N.C., June 13, 2018 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, today announced that John Ryals, PhD, has retired as its president and chief executive officer, but will remain on the company's ...Google News

GlobeNewswire (press release)Rohan Hastie Named as Metabolon CEO Following the Retirement of Its Co-Founder, John RyalsGlobeNewswire (press release)RESEARCH TRIANGLE PARK, N.C., June 13, 2018 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, today announced that John Ryals, PhD, has retired as its president and chief executive officer, but will remain on the company's ...

News-Medical.netThe Metabolome: An OverviewNews-Medical.netMetabolomics is the comprehensive study of metabolome present in cells, tissues, biological fluids, or organisms. Given the dynamic nature of metabolites, metabolomics can actually provide only a 'snapshot' of a metabolome in a given time, under ...

Rohan Hastie Named as Metabolon CEO Following the Retirement of Its Co-Founder, John Ryals  GlobeNewswireRESEARCH TRIANGLE PARK, N.C., June 13, 2018 (GLOBE NEWSWIRE) -- Metabolon, Inc., the global leader in metabolomics, today announced that John ...

News-Medical.netRecent Advances in Personalized MedicineNews-Medical.netOf late, blood transcriptomics and metabolomics are also being used to develop personalized medicines due to their fine accuracy and analytical capability. Both these fields use the general principle of OMICS and can provide a better understanding of ...

Metabolomics Market is Expected to Grow US$ 2.0 Billion By 2024Herald KeeperNew York, June 12, 2018: The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Lanxess AG, Akzo Nobel N.V ...and more »Google News

Metabolomics Market is Expected to Grow US$ 2.0 Billion By 2024Finance WireNew York, June 12, 2018: The metabolomics market is segmented on the lines of its technique, application and indication. The metabolomics market is segmented on the lines of its technique like separation techniques and detection techniques.and more »

Clean TechnologyMetabolomics Market Is Expected To Grow 14.54% CAGR till 2025Clean TechnologyMetabolomics is the scientific study of chemical processes involving metabolites. Specifically, metabolomics is the systematic study of the unique chemical fingerprints that specific cellular processes leave behind. The major players: Thermo Fisher ...Metabolomics Market is Expected to Grow US$ 2.0 Billion By 2024Finance Wireall 2 news articles »

Trade ChronicleGlobal Metabolomics Market Status, Key Trends and Foresight 2017-2026Trade ChronicleLatest industrial news that emphasis on Metabolomics market and offer a qualified and practical study. Upcoming prognosis for the Metabolomics market. The report evaluates complete Metabolomics business structure and facets related to industrial ...Metabolomics Market Professional Research Report 2017 with Competitive Landscape, Key manufacturers, Driving ...The Columnistall 2 news articles »

Metabolomics Market to touch US$2.49 bn by the end 2024 ...Exclusive ReportageThe global metabolomics market has been witnessing an escalating graph of competition over the past years. At every point in time, the market has surpassed ...and more »

Bringing in a new era of healthcare data  FelixOnlineGDPR is in full effect, and technology companies are sweating to work out the appropriate strategy to comply with new regulations governing digital data.

NMR-Based Prostate Cancer Metabolomics.UroTodayMetabolomics is the large-scale study of small molecules, commonly known as metabolites, within cells, biofluids, tissues, or organisms. Nuclear magnetic resonance (NMR) spectroscopy is commonly applied in metabolomics studies of cancer. This chapter ...

NMR-Based Prostate Cancer Metabolomics.UroTodayMetabolomics is the large-scale study of small molecules, commonly known as metabolites, within cells, biofluids, tissues, or organisms. Nuclear magnetic resonance (NMR) spectroscopy is commonly applied in metabolomics studies of cancer. This chapter ...

Hexokinase 2 Is Targetable for HK1-Negative, HK2-Positive Tumors from a Wide Variety of Tissues of Origin  Journal of Nuclear Medicine+ Author Affiliations. 1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, ...